Page last updated: 2024-12-07

5-oxo-prolyl-glycyl-arginine-4-nitroanilide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-oxo-prolyl-glycyl-arginine-4-nitroanilide: urokinase substrate; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID121898
SCHEMBL ID6171515
MeSH IDM0090983

Synonyms (18)

Synonym
opgan
74661-31-7
5-oxo-pro-gly-arg-4-nitroanilide
5-oxo-prolyl-glycyl-arginine-4-nitroanilide
chromogenic substrate s-2444
l-argininamide, 5-oxo-l-prolylglycyl-n-(4-nitrophenyl)-
s-2444 ,
5-oxo-l-prolylglycyl-l-arginine 4-nitroanilide
bdbm14716
l-pyroglutamyl-glycyl-l-argininep-nitroaniline hydrochloride
(2s)-5-carbamimidamido-n-(4-nitrophenyl)-2-(2-{[(2s)-5-oxopyrrolidin-2-yl]formamido}acetamido)pentanamide hydrochloride
SCHEMBL6171515
DGYWXYFLXYIOCP-KBPBESRZSA-N
pyroglu-gly-arg-p-nitroanilide
(s)-n-(2-((s)-5-guanidino-1-(4-nitrophenylamino)-1-oxopentan-2-ylamino)-2-oxoethyl)-5-oxopyrrolidine-2-carboxamide
pyr-gly-arg-pna
n-(2-{[5-carbamimidamido-1-(4-nitroanilino)-1-oxopentan-2-yl]imino}-2-hydroxyethyl)-5-hydroxy-3,4-dihydro-2h-pyrrole-2-carboximidic acid
DTXSID20996178

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"Thrombolytic therapy with Urokinase (UK) has often been successful but it is very difficult to determine the effective dosage of UK."( [The changes of alpha 2-plasmin inhibitor, and notably urokinase activities in blood measured by synthetic chromogenic substrates S-2444 after urokinase administration].
Ishihara, M; Itoh, Y; Kobayashi, M; Nakanishi, M; Tanaka, N; Tsuji, K; Yamada, M, 1983
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (38.46)18.7374
1990's12 (46.15)18.2507
2000's3 (11.54)29.6817
2010's1 (3.85)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.96

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.96 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index4.26 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.96)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]